Apogem Secondary Fund VII, LP — Form D/A
Apogem Secondary Fund VII, LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-02-13. The offering totals $1.3B, of which $1.2B was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-02-13
- Form: D/A
- Accession: 0001979709-26-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Total offering: $1.3B
- Amount sold: $1.2B
- Remaining: $86.3M
- Minimum investment: $1.0M
- Investors: 86
- Date of first sale: 2023-12-26
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-502132
Issuer
- Name: Apogem Secondary Fund VII, LP
- CIK: 0001979709
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 299 PARK AVENUE, NEW YORK, NY, 10171
- Phone: 212-601-3614
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| N/A Apogem Capital LLC | Related Person | New York, NY |
| N/A ASF VII GP, LLC | Related Person | New York, NY |
| John M Grady | Related Person | New York, NY |
| Michael Griech | Related Person | New York, NY |
| Christopher Stringer | Related Person | Richmond, VA |
| Michael Zeleniuch | Related Person | CHICAGO, IL |
| Christopher M Stringer | Executive Officer | New York, NY |
| Michael M Zeleniuch | Executive Officer | New York, NY |
| N/A M Apogem Capital LLC | Promoter | New York, NY |
| N/A ASF VII GP, LLC | Director | New York, NY |
| John M Grady | Executive Officer | New York, NY |
| Michael M Griech | Executive Officer | New York, NY |
Other filings by this issuer (2)
More